Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.7K Buy
246
+58
+31% +$5.46K ﹤0.01% 795
2026
Q1
$22.2K Buy
188
+58
+45% +$7.17K ﹤0.01% 670
2025
Q4
$16.4K Sell
130
-613
-83% -$80K ﹤0.01% 754
2025
Q3
$109K Sell
743
-161
-18% -$24.3K 0.01% 398
2025
Q2
$141K Sell
904
-93
-9% -$14.7K 0.01% 355
2025
Q1
$164K Hold
997
0.02% 301
2024
Q4
$162K Buy
997
+155
+18% +$27.7K 0.02% 316
2024
Q3
$147K Buy
842
+27
+3% +$4.97K 0.01% 336
2024
Q2
$141K Buy
815
+560
+220% +$93.2K 0.02% 319
2024
Q1
$43.1K Buy
+255
New +$47.8K 0.01% 283

Other funds holding ZTS

LRI Investments's ZTS Position: Q2 2026 in Review

LRI Investments increased its Zoetis (ZTS) stake by 31% in Q2 2026, buying an estimated $5.46K and bringing the position to 246 shares worth $17.7K. The position accounts for ﹤0.01% of the portfolio, ranked #795.

LRI Investments first reported a position in ZTS in Q1 2024 and has held it in 10 quarters since. The position peaked at $164K in Q1 2025. 274 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • LRI Investments held 246 shares of Zoetis worth $17.7K as of Q2 2026.
  • LRI Investments bought 58 Zoetis shares in Q2 2026, an estimated $5.46K.
  • Zoetis made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #795 holding.
  • LRI Investments first reported a position in Zoetis in Q1 2024 and has held it in 10 quarters since.
  • LRI Investments's Zoetis position peaked at $164K in Q1 2025.
  • 274 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.